Dr. William Mills III, University of Virginia, United States.

William A. Mills III, known as Tré, is a dedicated neuroscientist whose academic and professional journey reflects a strong commitment to translational and interdisciplinary research. With foundational training from Virginia Tech and international exposure through studies in China, Tré has developed a deep expertise in neurovascular coupling and glial biology. His doctoral and postdoctoral research has significantly advanced our understanding of how microglia and aging influence the brain’s vascular systems. Through prestigious fellowships and awards, including the NIH K99/R00 and the AHA Postdoctoral Fellowship, Tré has proven his potential to become a leading figure in neuroscience. His work bridges multiple scientific disciplines and focuses on uncovering mechanisms that contribute to neurological aging and disease.

Profile

Google Scholar

🎓 Early Academic Pursuits

William A. Mills III, fondly known as Tré, laid a solid foundation for his scientific career through rigorous and diverse academic training. He earned his Bachelor of Science degree in Biological Sciences from Virginia Tech in 2014, where he was actively involved in research labs focusing on virology, behavioral ecology, and disease ecology. His passion for cross-cultural and interdisciplinary learning was evident as he pursued Chinese language studies at Xi’an Jiaotong-Liverpool University from 2014 to 2015. This global academic exposure was followed by his Ph.D. in Translational Biology, Medicine & Health with a neuroscience focus at Virginia Tech (2015–2021), where he developed a strong interest in neurovascular and glial biology. These formative experiences created a well-rounded and curious scientist ready to tackle complex biomedical questions.

🧠 Professional Endeavors in Neuroscience

Tré’s professional journey took a pivotal turn when he joined the Eyo Lab at the University of Virginia as a Postdoctoral Research Fellow in 2021. His research investigates the intricate role of microglia in regulating capillary basal tone and neurovascular coupling—an area that sits at the intersection of neuroimmunology and vascular biology. His graduate years in the Sontheimer Lab had already shaped his expertise in glial signaling pathways, particularly focusing on the effects of aging on gliovascular interactions involving EGFR and pSTAT3. These experiences underscore a continuous commitment to understanding the cellular mechanisms that underpin brain function and disease.

🧪 Contributions and Research Focus

Throughout his research career, Tré has contributed significantly to the field of neurovascular biology and glial cell research. His scientific curiosity has spanned from studying the cellular mechanics of viral encapsidation in early projects to evaluating semaphorin roles in cardiovascular pathology. Notably, his doctoral work on gliovascular plasticity and his current postdoctoral focus on microglia’s role in cerebral blood flow regulation highlight his interdisciplinary approach. By bridging neuroscience, immunology, and vascular biology, he is shedding light on the fundamental processes that maintain brain health and how their disruption leads to age-related and neurodegenerative diseases.

🏅 Accolades and Recognition

Tré’s outstanding research potential has been recognized by several prestigious institutions. He was awarded the American Heart Association Career Development Award (which he respectfully declined), the American Heart Association Postdoctoral Fellowship (25POST1376070), and the UVA Brain Institute Postdoctoral Research Fellowship. In addition, he secured training support through the UVA Cardiovascular Research Center T32 Training Grant, reflecting the strong institutional belief in his capabilities. Most notably, he earned the competitive NIH K99/R00 Pathway to Independence Award, a mark of distinction for early-career researchers poised to transition to faculty positions.

🔬 Impact and Influence in Translational Neuroscience

Tré’s research contributions are highly translational in nature, linking basic cellular mechanisms to potential therapeutic implications in aging, stroke, and neurodegeneration. His work on microglial function in neurovascular coupling could provide new insights into how blood flow dysregulation contributes to cognitive decline and dementia. By exploring how aging alters glial and vascular interactions, Tré’s research holds the promise to inform interventions targeting the brain’s support systems to preserve function in aging populations. His influence is also visible through collaborative projects, lab mentorship, and participation in international research endeavors.

🌍 Legacy and Future Contributions

Looking ahead, Tré is poised to leave a lasting legacy in the field of neurovascular biology. With a trajectory marked by intellectual rigor, global awareness, and translational relevance, he is expected to lead pioneering studies that will redefine our understanding of brain support systems in health and disease. The foundation laid by his NIH K99/R00 award positions him well to establish an independent research program, where he will likely mentor future scientists and push the boundaries of neuroscience through integrative and innovative research methodologies.

🧬 A Champion of Interdisciplinary Science

A defining trait of Tré’s career is his seamless integration of diverse scientific fields—ranging from immunology and neuroscience to cardiovascular biology and behavioral ecology. This interdisciplinary ethos not only enriches his research output but also positions him as a bridge-builder in science, capable of uniting different perspectives to address complex biomedical challenges. His academic journey from microbiology and animal behavior to glial biology exemplifies a dynamic scientist committed to evolving with the science, while remaining grounded in his passion for discovery.

Publication

Title: Capillary-associated microglia regulate vascular structure and function through PANX1-P2RY12 coupling in mice
Authors: K. Bisht, K.A. Okojie, K. Sharma, D.H. Lentferink, Y.Y. Sun, H.R. Chen, …
Year: 2021

Title: Spatially expandable fiber-based probes as a multifunctional deep brain interface
Authors: S. Jiang, D.C. Patel, J. Kim, S. Yang, W.A. Mills III, Y. Zhang, K. Wang, Z. Feng, …
Year: 2020

Title: Astrocyte plasticity in mice ensures continued endfoot coverage of cerebral blood vessels following injury and declines with age
Authors: W.A. Mills III, A.L.M. Woo, S. Jiang, J. Martin, D. Surendran, M. Bergstresser, …
Year: 2022

Title: Lactobacillus rescues postnatal neurobehavioral and microglial dysfunction in a model of maternal microbiome dysbiosis
Authors: Y. Lebovitz, E.A. Kowalski, X. Wang, C. Kelly, M. Lee, V. McDonald, R. Ward, …
Year: 2019

Title: Potassium and glutamate transport is impaired in scar-forming tumor-associated astrocytes
Authors: S.C. Campbell, C. Muñoz-Ballester, L. Chaunsali, W.A. Mills III, J.H. Yang, …
Year: 2020

Title: LRRTM1 underlies synaptic convergence in visual thalamus
Authors: A. Monavarfeshani, G. Stanton, J. Van Name, K. Su, W.A. Mills III, K. Swilling, …
Year: 2018

Title: EphA4/Tie2 crosstalk regulates leptomeningeal collateral remodeling following ischemic stroke
Authors: B. Okyere, W.A. Mills, X. Wang, M. Chen, J. Chen, A. Hazy, Y. Qian, J.B. Matson, …
Year: 2020

Title: Nano-optoelectrodes integrated with flexible multifunctional fiber probes by high-throughput scalable fabrication
Authors: S. Jiang, J. Song, Y. Zhang, M. Nie, J. Kim, A.L. Marcano, K. Kadlec, …
Year: 2021

Title: The emergence of the calvarial hematopoietic niche in health and disease
Authors: W.A. Mills III, M.A. Coburn, U.B. Eyo
Year: 2022

Title: Using zebrafish to elucidate glial-vascular interactions during CNS development
Authors: R.A. Umans, C. Pollock, W.A. Mills III, K.C. Clark, Y.A. Pan, H. Sontheimer
Year: 2021

🧾 Conclusion

Tré stands out as a forward-thinking and highly skilled researcher whose contributions are shaping the future of neurovascular and glial research. His innovative approach, academic excellence, and recognition by top funding agencies underscore his suitability for leadership roles in neuroscience. As he transitions into an independent research career, Tré is expected to make enduring impacts on the scientific community through groundbreaking discoveries, mentorship, and interdisciplinary collaboration. His trajectory is a testament to his dedication, curiosity, and potential to transform brain health research.

Liliana Elena Weimer | Clinical Neuroscience | Best Researcher Award

Posted on 11/06/202511/06/2025 by Neuroscientists

Dr. Liliana Elena Weimer | Clinical Neuroscience | Best Researcher Award

Dr. Liliana Elena Weimer, Center For Global Health Istituto Superiore di Sanita’ Rome, Italy.

Dr. Liliana Elena Weimer is a highly accomplished physician and clinical researcher , where she has risen to the prestigious Level II “First Researcher” position. Her professional focus lies in clinical trials for infectious diseases, particularly HIV and Hepatitis C. She has played a critical role in major national and international research efforts, including collaborations with the U.S. Clinical Trials Group and leadership of the large-scale PITER cohort involving 25,000 HCV patients. She is known not only for her scientific contributions but also for her humanitarian efforts during the COVID-19 emergency. Among her recognitions is the 1st Prize at the 2019 International Congress on Hepatitis C in Seville. Throughout her career, she has exemplified scientific integrity, dedication, and service to public health.

Profile

Google Scholar

🎓 Early Academic Pursuits

Born on December 19, 1965, in Buenos Aires to Italian parents, Dr. Liliana Elena Weimer embraced her dual heritage and committed herself to a life in medicine and research. With Italian citizenship and deep academic determination, she laid the groundwork for her career by studying medicine, ultimately finding her professional home in Italy. Her academic path, though not fully detailed, clearly led her toward a focus on clinical medicine and infectious diseases, with her earliest professional roles marking the beginning of a lifelong engagement in public health and biomedical research. Her intellectual dedication and international roots later became an asset in global research collaborations.

🩺 Professional Endeavors

Dr. Weimer’s distinguished career spans over three decades at the Italian National Institute of Health (ISS), beginning in 1985. Starting as a dedicated clinical physician, she ascended to Level III researcher status by 1990 and continued to grow into higher ranks, culminating in her success in the national Art. 15 competition for the Level II “First Researcher” role in 2022, officially backdated to 2021. Throughout her tenure at ISS, she became a central figure within the Global Health Center in Rome. Known for her tireless commitment, she often described her career not simply as a job but as a “mission,” emphasizing both her personal and professional passion for making a difference in human health.

🧪 Contributions and Research Focus

Specializing in clinical trials, Dr. Weimer has coordinated and participated in numerous groundbreaking studies in HIV and Hepatitis C (HCV). Since the early 1990s, she has collaborated closely with renowned figures such as Prof. Giovanni Rossi, Prof. Stefano Vella, and Prof. Gianni Rezza, contributing to some of the most pivotal HIV antiretroviral therapy trials in history. Her research efforts extended to co-leading and organizing both national and international multicenter clinical trials. Notably, she has been at the forefront of the PITER study, a major nationwide cohort that follows 25,000 patients undergoing HCV treatment—one of the most comprehensive initiatives in Italy in the fight against hepatitis.

🌍 Global Collaborations and Humanitarian Engagement

Her impact extends beyond Italy, thanks to her active involvement with the U.S.-based American Clinical Trials Group on HIV studies. These collaborations have enhanced international understanding and treatment of HIV/AIDS. In addition to her clinical and research commitments, Dr. Weimer also devoted herself to frontline service during the COVID-19 pandemic. Volunteering both with the Civil Protection unit and at Bambino Gesù Children’s Hospital, she demonstrated profound humanitarian values. Her presence during a critical time underscored her belief in serving communities not just from behind a lab desk but also on the ground, directly supporting patients and health systems under strain.

🏅 Accolades and Recognition

Dr. Weimer’s work has been acknowledged at both national and international levels. One of the most prominent recognitions she received was the 1st Prize at the International Congress on Hepatitis C held in Seville in November 2019, a testament to her excellence and influence in the field of infectious disease research. Her achievements are not only measured in accolades but also in the tangible difference her work has made in advancing therapy options and clinical management of chronic viral diseases. Her rise within the ISS and the trust placed in her leadership of major research projects further affirm her standing within the scientific community.

💡 Impact and Influence

Over the course of her extensive career, Dr. Weimer has significantly shaped clinical research strategies in Italy, especially regarding chronic viral infections. Her coordination of thousands of patient cases within structured clinical trials has informed policy decisions and improved treatment protocols nationwide. Her presence at the ISS has also influenced future generations of researchers and clinicians, many of whom benefited from her mentorship, leadership, and example of scientific integrity. Through her rigorous methods and patient-focused approach, she has played a key role in Italy’s standing as a leader in global health research, especially in relation to HIV and HCV.

🔬 Legacy and Future Contributions

Looking forward, Dr. Weimer’s contributions will continue to echo through the fields of virology and clinical medicine. Her involvement in the PITER cohort and other studies has laid down essential groundwork for long-term epidemiological surveillance and patient care strategies. With her appointment as First Researcher, she enters a new chapter of leadership, likely to drive more innovative, patient-centered research initiatives in global health. Her legacy lies not only in her publications or awards but also in the thousands of lives improved by the treatments she helped to test, refine, and implement. The combination of scientific rigor and heartfelt service defines her enduring contribution to modern medicine.

Publication

Outcome of sustained virological responders with histologically advanced chronic hepatitis C – TR Morgan, MG Ghany, HY Kim, KK Snow, ML Shiffman, JL De Santo, … – 2010

Clinical, virologic, histologic, and biochemical outcomes after successful HCV therapy: a 5‐year follow‐up of 150 patients – SL George, BR Bacon, EM Brunt, KL Mihindukulasuriya, J Hoffmann, … – 2009

Safety and efficacy of simeprevir/sofosbuvir in hepatitis C–infected patients with compensated and decompensated cirrhosis – V Saxena, L Nyberg, M Pauly, A Dasgupta, A Nyberg, B Piasecki, … – 2015

Slow human immunodeficiency virus type 1 evolution in viral reservoirs in infants treated with effective antiretroviral therapy – D Persaud, SC Ray, J Kajdas, A Ahonkhai, GK Siberry, K Ferguson, … – 2007

Evaluation of proton pump inhibitor use on treatment outcomes with ledipasvir and sofosbuvir in a real‐world cohort study – EB Tapper, BR Bacon, MP Curry, DT Dieterich, SL Flamm, LE Guest, … – 2016

Microbial translocation is associated with residual viral replication in HAART-treated HIV+ subjects with< 50 copies/ml HIV-1 RNA – S Baroncelli, CM Galluzzo, MF Pirillo, MG Mancini, LE Weimer, … – 2009

Predictors of failure with high-flow nasal oxygen therapy in COVID-19 patients with acute respiratory failure: a multicenter observational study – R Mellado-Artigas, LE Mujica, ML Ruiz, BL Ferreyro, F Angriman, E Arruti, … – 2021

A randomized, double-blind trial on the use of a triple combination including nevirapine, a nonnucleoside reverse transcriptase HIV inhibitor, in antiretroviral-naive patients – M Floridia, R Bucciardini, D Ricciardulli, V Fragola, MF Pirillo, LE Weimer, … – 1999

Modeling cost‐effectiveness and health gains of a “universal” versus “prioritized” hepatitis C virus treatment policy in a real‐life cohort – LA Kondili, F Romano, FR Rolli, M Ruggeri, S Rosato, MR Brunetto, … – 2017

Real-life data on potential drug-drug interactions in patients with chronic hepatitis C viral infection undergoing antiviral therapy with interferon-free DAAs in the PITER network – LA Kondili, GB Gaeta, D Ieluzzi, AL Zignego, M Monti, A Gori, A Soria, … – 2017

🏁 Conclusion

Dr. Weimer stands as a distinguished figure in the field of global health research, with deep expertise in clinical trials and infectious diseases. Her legacy is marked by landmark contributions to HIV and HCV treatment protocols, influential collaborations, and compassionate public service. Her ongoing work continues to shape public health policy and medical research in Italy and beyond. As she advances in her leadership role at the ISS, her experience, insight, and dedication will remain vital to future innovations in clinical research and global health.

Chen Shoubin | Behavioral Neuroscience | Best Researcher Award

Posted on 30/04/2025 by Neuroscientists

Dr. Chen Shoubin | Behavioral Neuroscience | Best Researcher Award

Dr. Chen Shoubin, Shenzhen University, China.

Dr. Shoubin Chen is a forward-thinking Research Fellow at the Guangdong Laboratory of Artificial Intelligence and Digital Economy (Shenzhen), affiliated with Shenzhen University. With a Ph.D. in Photogrammetry and Remote Sensing, his career has been rooted in the intersection of spatial intelligence, robotics, and AI. From leading national research projects to publishing in reputable journals and securing multiple invention patents, Dr. Chen has made substantial contributions to the field of embodied intelligent robotics. His research emphasizes multi-sensor fusion and autonomous mapping, aiming to give machines human-like spatial perception and decision-making capabilities.

Profile

Google Scholar

📚 Early Academic Pursuits

Shoubin Chen’s academic journey began with a strong foundation in geospatial sciences, culminating in a Ph.D. in Photogrammetry and Remote Sensing in 2020. This prestigious degree was awarded through a rigorous joint training program between Wuhan University and the Finnish Geospatial Research Institute. During his doctoral studies, he developed a deep interest in integrating advanced spatial data techniques with artificial intelligence, laying the groundwork for his future research endeavors. His early academic phase was marked by a commitment to cross-border scientific collaboration and multidisciplinary exploration, which has since defined his research approach.

🧑‍💻 Professional Endeavors

Currently serving as a Research Fellow and graduate supervisor at the Guangdong Laboratory of Artificial Intelligence and Digital Economy (Shenzhen) and Shenzhen University, Dr. Chen plays a pivotal role in advancing embodied intelligence within the Spatial Intelligence Team. His responsibilities include mentoring postgraduate students, overseeing cutting-edge research, and steering major national and provincial scientific projects. He has contributed to several national-level initiatives, including two National Natural Science Foundation of China grants, support from the China Postdoctoral Science Foundation, and sub-projects under the National Key Research and Development Program. These experiences have sharpened his expertise in high-precision robotic mapping and autonomous navigation.

🤖 Contributions and Research Focus

Dr. Chen’s primary research focus lies in embodied intelligent robotics, with an emphasis on multi-sensor fusion, robotic perception, and spatial mapping technologies. He is recognized for integrating data from various sensing modalities to improve the autonomy and spatial awareness of robotic systems. His innovations aim to empower robots with human-like spatial understanding, allowing them to operate reliably in complex environments. This research direction is crucial for applications ranging from autonomous vehicles to intelligent service robots, contributing significantly to the frontier of AI-driven robotics.

🏅 Accolades and Recognition

Throughout his academic and professional career, Shoubin Chen has garnered considerable recognition for his scientific excellence. He has published nearly ten high-quality papers as either the first or corresponding author in SCI Q2 journals and CCF B-tier or higher conferences and journals. Moreover, he has applied for over ten invention patents, underscoring his commitment to both theoretical advancement and practical application. His reputation in the academic community is further highlighted by his service as a peer reviewer for prestigious platforms such as the IEEE Internet of Things Journal, Remote Sensing of Environment, IEEE Transactions on Intelligent Vehicles, and ICRA, one of the top robotics conferences globally.

🌐 Impact and Influence

Dr. Chen’s work has had a profound impact on the fields of AI, robotics, and spatial computing. His multi-disciplinary approach has influenced how robots understand and interact with their environments, offering transformative possibilities in smart cities, autonomous transport, and digital mapping. By fusing photogrammetry with robotics and AI, he has contributed to a new paradigm in spatial intelligence that bridges digital perception and physical action. His projects have not only generated academic outputs but have also driven technological innovations with potential for real-world deployment.

🌱 Legacy and Future Contributions

As a mentor, innovator, and research leader, Shoubin Chen continues to inspire the next generation of scientists and engineers in AI and robotics. His forward-looking vision involves deepening the integration of embodied intelligence with environmental understanding, enabling machines to collaborate more intuitively with humans. He is poised to expand his research to include human-robot interaction, sustainable urban intelligence, and smart sensing systems. With a growing portfolio of publications, patents, and mentorship experiences, his contributions are set to leave a lasting legacy in the development of intelligent systems that seamlessly bridge perception and action.

🔬 Vision in Artificial Intelligence and Robotics

Guided by a vision that combines spatial science with artificial cognition, Dr. Chen’s work embodies the future of AI-powered robotics. His pursuit of intelligent, context-aware robotic systems aligns with global goals in automation, smart infrastructure, and digital economy. As AI becomes increasingly pervasive in everyday life, his contributions are steering the technology toward safer, more efficient, and more interactive systems. Through continuous innovation and collaboration, he remains at the forefront of a transformative research frontier that blends engineering precision with visionary thinking.

Publication

Title: Exploring embodied multimodal large models: Development, datasets, and future directions
Authors: S Chen, Z Wu, K Zhang, C Li, B Zhang, F Ma, FR Yu, Q Li
Year: 2025

Title: Distributed Robust Communication-Efficient Multi-Robot SLAM Combining Real-Time Intersection and Historical Loop Constraints
Authors: B Zhang, Z Xiong, J Qiu, S Chen, Y Hu, S Chen
Year: 2025

Title: TextGeo-SLAM: A LiDAR SLAM With Text Semantics and Geometric Constraints-Based Loop Closure
Authors: S Chen, C Li, Q Jiang, X Zhuang, B Zhang, B Zhou, Q Li
Year: 2024

Title: ASL-SLAM: A LiDAR SLAM with activity semantics-based loop closure
Authors: B Zhou, C Li, S Chen, D Xie, M Yu, Q Li
Year: 2023

Title: Comparative analysis of SLAM algorithms for mechanical LiDAR and solid-state LiDAR
Authors: B Zhou, D Xie, S Chen, H Mo, C Li, Q Li
Year: 2023

Title: Research on SLAM based on LiDAR/visual fusion (LV-SLAM)
Authors: C Shoubin
Year: 2023

Title: Cooperative smartphone GNSS/PDR for pedestrian navigation
Authors: C Jiang, Y Chen, C Chen, S Chen, Q Meng, Y Bo, J Hyyppa
Year: 2022

Title: Indoor Attitude Estimation Using Equipped Gyroscopes and Depth Sensors
Authors: Q Shi, Z Song, Z Xiao, S Chen, F Wang
Year: 2022

Title: LI-SLAM: Fusing LiDAR and Infrared Camera for Simultaneous Localization and Mapping
Authors: B Zhou, D Xie, S Chen, C Li, H Mo
Year: 2022

Title: NDT-LOAM: A real-time LiDAR odometry and mapping with weighted NDT and LFA
Authors: S Chen, H Ma, C Jiang, B Zhou, W Xue, Z Xiao, Q Li
Year: 2021

✅ Conclusion

In conclusion, Dr. Shoubin Chen exhibits all the core qualities of a Best Researcher Award recipient: deep scientific insight, proven research leadership, strong publication and patent output, and a visionary approach to solving real-world problems through AI and robotics. While there are opportunities to grow his international footprint, his current accomplishments already place him among the leading young researchers in his field. Based on the evidence of impact, innovation, and research excellence, he is highly suitable for the Best Researcher Award.

CARMINA MONTOLIU | Clinical Neuroscience | Best Researcher Award

Posted on 26/04/2025 by Neuroscientists

Prof. Dr. CARMINA MONTOLIU | Clinical Neuroscience | Best Researcher Award

Prof. Dr. CARMINA MONTOLIU, UNIVERSIDAD DE VALENCIA/INCLIVA, Spain.

Carmina Montoliu Felix, a Valencia-born scientist and educator, is a distinguished Catedrática de Universidad at the Universidad de Valencia, specializing in Cellular Biology and Pathology. With a strong foundation in biomedical sciences and a dual role in both academia and clinical research through INCLIVA, she has become a key figure in translational medicine in Spain. Her work focuses on uncovering cellular mechanisms of disease, supported by national recognition such as her Group A classification by ISCIII. With extensive contributions indexed on platforms like ORCID and Scopus, she has gained international visibility and continues to influence the fields of pathology and biomedicine.

Profile

Orcid

🎓 Early Academic Pursuits

Carmina Montoliu Felix was born in Valencia, where she also pursued her academic career rooted in the life sciences. Her early interest in biology and medical sciences led her through a rigorous academic pathway that would eventually shape her into a leading figure in cellular pathology. With a profound dedication to understanding human disease at the cellular level, she cultivated a strong foundation in biology, which became the cornerstone of her future specialization in Cellular Biology and Pathology. These formative years instilled in her a passion for translational research, which continues to drive her work.

🏛️ Professional Endeavors

Currently serving as a Catedrática de Universidad at the Facultad de Medicina y Odontología of the Universidad de Valencia, Carmina Montoliu Felix holds a prestigious position within the Departamento de Patología, specifically in the Unidad de Biología. She achieved this distinguished academic rank on November 3, 2023, under BOE nº 274, a recognition of her academic excellence and contributions to higher education. Alongside her academic post, she is also an investigadora adscrita at the Fundación INCLIVA, playing a dual role in both teaching and active biomedical research. Her employment reflects the seamless integration between university instruction and clinical research aimed at improving patient outcomes.

🧬 Contributions and Research Focus

Carmina Montoliu Felix has been a pivotal contributor to the field of Cellular Biology, with specific expertise in Pathology (Área 661). Since February 29, 2012, she has been classified as a Group A Researcher within the Instituto de Salud Carlos III (ISCIII) framework. Her research activities are aligned with the Programa de Estabilización de Investigadores and the Sistema Nacional de Salud (I3SNS), focusing on intensifying biomedical research and fostering translational discoveries. Her scientific work is characterized by its interdisciplinary nature and commitment to uncovering the molecular basis of diseases, contributing significantly to both national and international health research landscapes.

🏅 Accolades and Recognition

Dr. Montoliu Felix’s academic excellence has been affirmed through numerous accolades, including the Group A classification by the Comisión Técnica de Evaluación de Recursos Humanos del ISCIII, one of the highest distinctions for biomedical researchers in Spain. Her appointment as a full professor is a testament to her leadership in medical education and scientific research. She is widely recognized among her peers for her scholarly impact, rigor, and commitment to nurturing future scientists and medical professionals.

🌍 Impact and Influence

Her work not only resonates within academic circles but also extends into clinical research through her active role at INCLIVA. By integrating research and practice, Carmina Montoliu Felix exemplifies how scientific inquiry can lead to tangible health benefits. Her influence spans collaborations with national healthcare systems and academic institutions, reinforcing her role as a key figure in the biomedical field. Through platforms such as ORCID and Scopus (ORCID ID: 0000-0002-4740-4788; Scopus ID: 6701923138), her contributions are accessible globally, further amplifying her scientific impact.

🔬 Legacy and Future Contributions

With a career marked by consistent advancement and dedication to discovery, Carmina Montoliu Felix is poised to continue shaping the future of cellular pathology and biomedical research in Spain and beyond. Her dual engagement in academia and clinical research ensures that her legacy will include both scientific breakthroughs and a generation of inspired students and researchers. Looking ahead, she is expected to further expand the integration of molecular biology into clinical diagnostics, ultimately improving patient care through science.

📚 A Life Committed to Science and Society

Beyond her technical expertise and professional roles, Carmina Montoliu Felix embodies the ideals of a scholar deeply committed to the betterment of society through science. Her residence and professional base in Valencia, her continuous academic contributions, and her service within public institutions paint the portrait of a researcher who bridges the lab and the community. Through her enduring efforts, she not only advances knowledge but also enhances the collective understanding of human health and disease.

Publication

Title: Valproate Damaging Effect on Erythrocyte Metabolism as a Decisive Factor in the Development of Encephalopathy
Authors: Lyudmila Tikhonova; Eugene Maevsky; Carmina Montoliu; Elena Kosenko
Year: 2025

Title: Ammoniagenic Action of Valproate without Signs of Hepatic Dysfunction in Rats: Possible Causes and Supporting Evidence
Authors: Gubidat Alilova; Lyudmila Tikhonova; Carmina Montoliu; Elena Kosenko
Year: 2024

Title: Automatic Video-Oculography System for Detection of Minimal Hepatic Encephalopathy Using Machine Learning Tools
Authors: Alberto Calvo Córdoba; Cecilia Elisabet García Cena; Carmina Montoliu
Year: 2023

Title: Neurofilament Light Chain Protein in Plasma and Extracellular Vesicles Is Associated with Minimal Hepatic Encephalopathy and Responses to Rifaximin Treatment in Cirrhotic Patients
Authors: Alessandra Fiorillo; Juan José Gallego Roig; Franc Casanova; Amparo Urios; MP Ballester; Teresa San-Miguel; Javier Megías Vericat; Elena Kosenko; Tosca J; Maria-Pilar Rios et al.
Year: 2023

Title: Mild Cognitive Impairment Is Associated with Enhanced Activation of Th17 Lymphocytes in Non-Alcoholic Fatty Liver Disease
Authors: Alessandra Fiorillo; Juan José Gallego Roig; Franc Casanova; Carla Giménez-Garzó; Amparo Urios; MP Ballester; Lucia Durbán; Maria-Pilar Rios; Javier Megías Vericat; Teresa San-Miguel et al.
Year: 2023

Title: Erythrocytes Functionality in SARS-CoV-2 Infection: Potential Link with Alzheimer’s Disease
Authors: Elena Kosenko; Lyudmila Tikhonova; Gubidat Alilova; Carmina Montoliu
Year: 2023

Title: Plasma Extracellular Vesicles Play a Role in Immune System Modulation in Minimal Hepatic Encephalopathy
Authors: Juan José Gallego; Alessandra Fiorillo; Franc Casanova-Ferrer; Amparo Urios; MP Ballester; Lucia Durbán; Javier Megías; Teresa Rubio; Andrea Cabrera-Pastor; Desamparados Escudero-García et al.
Year: 2022

Title: Matched Paired Primary and Recurrent Meningiomas Points to Cell-Death Program Contributions to Genomic and Epigenomic Instability along Tumor Progression
Authors: Teresa San-Miguel; Javier Megías; Daniel Monleon; Lara Navarro Cerveró; Lisandra Muñoz; Carmina Montoliu; Marina Meri; Pedro Roldán; Miguel Cerdá-Nicolás; Concha López-Ginés
Year: 2022

Title: Is NMDA-Receptor-Mediated Oxidative Stress in Mitochondria of Peripheral Tissues the Essential Factor in the Pathogenesis of Hepatic Encephalopathy?
Authors: Elena Kosenko; Lyudmila Tikhonova; Gubidat Alilova; Carmina Montoliu
Year: 2022

Title: A New Score Unveils a High Prevalence of Mild Cognitive Impairment in Patients with Nonalcoholic Fatty Liver Disease
Authors: Carla Giménez-Garzó; Alessandra Fiorillo; MP Ballester; Juan José Gallego Roig; Franc Casanova-Ferrer; Amparo Urios; Salvador Benlloch; Marti-Aguado D; Teresa San-Miguel; Tosca J et al.
Year: 2021

✅ Conclusion

Carmina Montoliu Felix’s career reflects a rare blend of scientific rigor, academic leadership, and social impact. Her journey from student to full professor showcases her dedication to advancing both knowledge and healthcare. As she continues to lead research at the intersection of cellular biology and clinical application, her legacy will not only be measured in published studies and prestigious titles, but also in the real-world health outcomes and inspired minds her work cultivates. Her future contributions promise to deepen our understanding of disease and strengthen the bridge between science and society.

Dong Ju | Neurotoxicology | Best Researcher Award

Posted on 08/04/2025 by Neuroscientists

Assoc. Prof.Dr. Dong Ju | Neurotoxicology | Best Researcher Award

Assoc. Prof. Dr. Dong Ju, Nanjing university of Chinese Medicine, China.

Ju Dong, an associate professor at Nanjing University of Chinese Medicine, has dedicated his academic and research career to ensuring the safety and scientific understanding of traditional Chinese medicine, particularly focusing on arsenic-containing compounds like realgar. His studies explore the genotoxic and neurotoxic effects of these substances and how formula compatibility can mitigate their risks. With 18 published papers and key roles in three national research projects, Ju Dong exemplifies a commitment to advancing evidence-based integration of Chinese and Western medical systems. His work bridges centuries-old wisdom with contemporary science, ensuring ancient remedies are both effective and safe for modern use.

profile

Scopus

🎓 Early Academic Pursuits

Ju Dong embarked on his academic journey with a deep-rooted passion for traditional Chinese medicine (TCM), particularly focusing on its safety and scientific validation. His early education laid a strong foundation in pharmacology and toxicology, nurturing an inquisitive mind eager to bridge the ancient wisdom of Chinese medicine with modern scientific methodologies. His dedication to scholarly excellence led him to advanced studies, ultimately shaping his future as a leading researcher in the field of integrative medicine.

🧪 Professional Endeavors

Currently serving as an associate professor at Nanjing University of Chinese Medicine, Ju Dong has established himself as a committed educator and researcher. His academic career has been marked by a dedication to both teaching and innovation, inspiring students while simultaneously advancing research that enhances the credibility and safety of traditional remedies. His professional efforts are driven by a vision to ensure that age-old formulations are scientifically evaluated and responsibly used in clinical settings.

🧠 Contributions and Research Focus

Ju Dong’s research primarily revolves around the safety of arsenic-containing traditional Chinese medicines, especially realgar. He has undertaken a systematic investigation into the genotoxicity and neurotoxicity associated with realgar and its compound formulas. His work also explores how formula compatibility within traditional Chinese prescriptions can mitigate these toxic effects. This research not only preserves the efficacy of realgar-based therapies but also ensures their safe use in modern integrative medicine practices.

📚 Academic Output and Recognition

As a passionate scholar, Ju Dong has presided over or actively contributed to three major projects under the National Natural Science Foundation of China. He has published 18 academic papers as the first or corresponding author, reflecting his consistent output and leadership in the field. His work is recognized for its depth and rigor, significantly contributing to evidence-based practices in both Chinese and Western medicine.

🌐 Evidence-Based Integration

One of Ju Dong’s most profound contributions lies in his advocacy for evidence-based medicine in the integration of traditional Chinese and Western healthcare systems. His research serves as a crucial bridge between ancient medical practices and contemporary clinical standards. By applying rigorous scientific methods to traditional remedies, he paves the way for holistic healthcare solutions that are both time-honored and scientifically validated.

🏅 Accolades and Professional Integrity

Though modest about his accolades, Ju Dong’s role in national projects and scholarly publications signifies the recognition he holds within academic and scientific circles. His unwavering professional ethics and transparent self-declaration reflect a commitment to integrity and accountability—core values that reinforce his credibility as a researcher and educator.

🌱 Legacy and Future Contributions

Looking ahead, Ju Dong aspires to deepen his research into toxicity mechanisms and formulation safety in TCM, contributing to safer medical practices and global acceptance of traditional remedies. His vision includes nurturing future scholars, expanding collaborative research networks, and continuing to advocate for rigorous scientific validation of traditional medicine. Through his work, he leaves a legacy of harmonizing tradition with innovation, ensuring that the wisdom of the past can safely inform the medicine of tomorrow.

Publication

Title: The alleviation effect and its mechanism of Niuhuang Jiedu prescription on realgar-induced genotoxicity in mice
Authors: Dong J., Wang Y., Qian Q., Yang D., Liu D.
Year: 2024

✅ Conclusion

Ju Dong’s contributions stand at the critical intersection of tradition and innovation. By combining deep-rooted knowledge of Chinese medicine with scientific scrutiny, he champions a future where integrative medicine is both culturally respectful and clinically validated. His research not only preserves the heritage of traditional medicine but also ensures its responsible use in modern healthcare. As he continues to explore safer and more effective ways to utilize ancient formulas, Ju Dong’s work lays a vital foundation for the global credibility and acceptance of traditional Chinese medical practices.

Hiroshi Yamada | Neuroscience | Excellence in Innovation

Posted on 04/02/202504/02/2025 by Neuroscientists

Mr. Hiroshi Yamada | Neuroscience | Excellence in Innovation

Mr. Hiroshi Yamada, Medical/Tsukuba, Japan.

H. Yamada, born in Kasugai, Aichi, Japan, has built an impressive academic and professional career in neuroscience. After earning his Bachelor of Science from Tohoku University, he pursued a Master’s degree at Osaka University and later obtained his Ph.D. from Kyoto Prefectural University of Medicine. His research journey took him from postdoctoral studies in Japan to New York University, where he collaborated with renowned neuroscientist Paul W. Glimcher. Returning to Japan, he served as Section Chief at the National Center of Neurology and Psychiatry before joining the University of Tsukuba, where he progressed from Assistant Professor to Associate Professor. His research focuses on neural mechanisms, contributing significantly to neuroscience through both theoretical and practical advancements.

Profile

Google Scholar

🎓 Early Academic Pursuits

H. Yamada’s academic journey reflects a deep-rooted passion for science and medicine. Born on September 9, 1977, in Kasugai, Aichi, Japan, he pursued a Bachelor of Science degree from the Faculty of Science at Tohoku University, graduating in 2000. Driven by a desire to deepen his understanding of human biology, he earned his Master of Arts from the Faculty of Medicine at Osaka University in 2002. His academic pursuits culminated in a Ph.D. from the Graduate School of Kyoto Prefectural University of Medicine in 2005, where he laid the groundwork for his future research in neuroscience.

🧠 Professional Endeavors in Neuroscience

H. Yamada’s professional career began with postdoctoral research at Kyoto Prefectural University of Medicine under the mentorship of Minoru Kimura, focusing on advanced neurological studies. His pursuit of global scientific exposure led him to New York University in 2008, where he worked with renowned neuroscientist Paul W. Glimcher. Upon returning to Japan, Yamada took on a leadership role as Section Chief at the National Center of Neurology and Psychiatry, National Institute of Neuroscience, from 2011. This role was pivotal in shaping his expertise in neurological research, ultimately leading to his tenure as Assistant Professor at the University of Tsukuba in 2013, and later as Associate Professor in 2022.

🔬 Contributions and Research Focus

Throughout his career, H. Yamada has been dedicated to unraveling the complexities of the human brain. His research primarily focuses on neuroscience, exploring neural mechanisms underlying behavior and cognition. At the University of Tsukuba, he has contributed significantly to the understanding of brain functions, merging experimental data with theoretical models to advance the field. His collaborations with international experts have enriched his approach, making his work both diverse and impactful.

🏅 Accolades and Recognition

Yamada’s contributions to neuroscience have earned him recognition within the academic community. His leadership roles and tenured position at the University of Tsukuba reflect his outstanding research and teaching capabilities. His work at prestigious institutions like New York University and the National Center of Neurology and Psychiatry has further solidified his reputation as a respected neuroscientist, contributing to both national and international scientific advancements.

🌍 Impact and Influence

H. Yamada’s research has had a profound impact on the field of neuroscience, influencing both academic circles and clinical practices. His studies on neural behavior have provided insights that bridge the gap between theoretical neuroscience and practical applications, aiding in the development of treatments for neurological disorders. As an educator, he has mentored numerous students, fostering the next generation of neuroscientists.

🚀 Legacy and Future Contributions

Looking ahead, H. Yamada is committed to expanding the horizons of neuroscience through innovative research and global collaborations. His legacy is not only reflected in his published work but also in the students and researchers he has inspired. As he continues his journey at the University of Tsukuba, his focus remains on advancing scientific knowledge and contributing to the global understanding of the human brain.

💡 A Lifelong Dedication to Science

H. Yamada’s life is a testament to the power of curiosity and dedication. From his early academic days in Tohoku to his current role as an Associate Professor, he has consistently pursued excellence in neuroscience. His journey underscores the importance of interdisciplinary research, mentorship, and the relentless quest for knowledge, leaving a lasting mark on the scientific community.

Publication

Title: Tonically active neurons in the primate caudate nucleus and putamen differentially encode instructed motivational outcomes of action
Authors: H. Yamada, N. Matsumoto, M. Kimura
Year: 2004

Title: Roles of the lateral habenula and anterior cingulate cortex in negative outcome monitoring and behavioral adjustment in nonhuman primates
Authors: T. Kawai, H. Yamada, N. Sato, M. Takada, M. Matsumoto
Year: 2015

Title: Thirst-dependent risk preferences in monkeys identify a primitive form of wealth
Authors: H. Yamada, A. Tymula, K. Louie, P.W. Glimcher
Year: 2013

Title: Juxtacellular labeling of tonically active neurons and phasically active neurons in the rat striatum
Authors: H. Inokawa, H. Yamada, N. Matsumoto, M. Muranishi, M. Kimura
Year: 2010

Title: Free choice shapes normalized value signals in medial orbitofrontal cortex
Authors: H. Yamada, K. Louie, A. Tymula, P.W. Glimcher
Year: 2018

Title: Tonically active neurons in the striatum encode motivational contexts of action
Authors: M. Kimura, H. Yamada, N. Matsumoto
Year: 2003

Title: Tonic firing mode of midbrain dopamine neurons continuously tracks reward values changing moment-by-moment
Authors: Y. Wang, O. Toyoshima, J. Kunimatsu, H. Yamada, M. Matsumoto
Year: 2021

Title: Roles of centromedian parafascicular nuclei of thalamus and cholinergic interneurons in the dorsal striatum in associative learning of environmental events
Authors: K. Yamanaka, Y. Hori, T. Minamimoto, H. Yamada, N. Matsumoto, et al.
Year: 2018

Title: Inactivation of the putamen selectively impairs reward history-based action selection
Authors: M. Muranishi, H. Inokawa, H. Yamada, Y. Ueda, N. Matsumoto, M. Nakagawa, et al.
Year: 2011

Title: Goal-directed, serial and synchronous activation of neurons in the primate striatum
Authors: M. Kimura, N. Matsumoto, K. Okahashi, Y. Ueda, T. Satoh, T. Minamimoto, et al.
Year: 2003

Conclusion

H. Yamada’s career is a reflection of his dedication to advancing the understanding of the human brain. His academic achievements, leadership roles, and research contributions have left a lasting impact on the neuroscience community. As he continues his work at the University of Tsukuba, his legacy is defined not only by his scientific discoveries but also by his mentorship and influence on future generations of researchers. His journey stands as an inspiring example of the pursuit of knowledge and the transformative power of science.